NRIM vs BCAL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

NRIM

48.4
AI Score
VS
BCAL Wins

BCAL

51.1
AI Score

Investment Advisor Scores

NRIM

48score
Recommendation
HOLD

BCAL

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NRIM BCAL Winner
Forward P/E 12.7714 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -20.0% -5.2% BCAL
Earnings Growth -47.5% -10.4% BCAL
Tradestie Score 48.4/100 51.1/100 BCAL
Profit Margin 27.6% 32.2% BCAL
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NRIM 1M: -2.1% · 3M: -11.3% BCAL 1M: +2.7% · 3M: +1.2%

Current Technical Phase

NRIM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $23.90

BCAL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.7% over 20 days), RSI 56

RSI (14): 55.5 · Price: $22.06

Fundamentals Snapshot

Metric NRIM BCAL
Market Cap — —
Forward P/E 8.8 11.8
Trailing P/E 9.5 12.2
Revenue (TTM) — —
Revenue Growth -0.2% -0.1%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.5%
EPS 2.51 1.81
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, BCAL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.